Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
13 studies found for:    glioblastoma | Open Studies | Interventional Studies | Phase 3
Show Display Options
Rank Status Study
1 Recruiting Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
Condition: Glioblastoma
Interventions: Procedure: Standard surgery (neuronavigation-guided);   Radiation: Intraoperative radiotherapy;   Radiation: Radiochemotherapy;   Drug: Temozolomide
2 Recruiting Phase III Study Comparing 2 Brain Conformational Radiotherapy in Combination With Chemotherapy in the Treatment of Glioblastoma
Condition: Glioblastoma
Interventions: Radiation: Radiotherapy;   Radiation: Experimental arm
3 Recruiting Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma
Condition: Glioblastoma Multiforme
Interventions: Biological: ICT-107;   Biological: Placebo
4 Recruiting Bevacizumab Alone Versus Dose-dense Temozolomide Followed by Bevacizumab for Recurrent Glioblastoma, Phase III
Conditions: Glioblastoma;   Recurrence;   Progression
Interventions: Drug: Temozolomide;   Drug: Bevacizumab
5 Recruiting An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
Condition: Brain Cancer
Interventions: Drug: Nivolumab;   Drug: Temozolomide;   Radiation: Radiotherapy
6 Not yet recruiting VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM
Conditions: Glioblastoma Multiforme;   Glioblastoma;   Glioma;   GBM;   Brain Cancer
Interventions: Drug: VAL-083, Dianhydrogalactitol;   Drug: Physician's Choice of Salvage Therapy - temozolomide;   Drug: Physician's Choice of Salvage Therapy - lomustine;   Drug: Physician's Choice of Salvage Therapy - carboplatin
7 Recruiting Disulfiram in Recurrent Glioblastoma
Conditions: Glioma;   Glioblastoma
Interventions: Drug: Disulfiram;   Dietary Supplement: Copper;   Drug: Alkylating Agents
8 Not yet recruiting A Phase II/III Study of High-dose, Intermittent Sunitinib in Patients With Recurrent Glioblastoma Multiforme
Conditions: Glioblastoma Multiforme;   Glioblastoma, Adult;   Glioblastoma;   Recurrent Brain Tumor;   GBM
Interventions: Drug: Sunitinib;   Drug: Lomustine
9 Not yet recruiting Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM
Condition: Glioblastoma
Interventions: Radiation: CCRT;   Drug: Temozolomide;   Drug: Siroquine
10 Not yet recruiting The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients
Conditions: GBM;   Depression
Interventions: Drug: Escitalopram;   Drug: placebo
11 Recruiting A Study on β-elemene as Maintain Treatment for Complete Remission Patients of Newly Diagnosed Malignant Gliomas Following Standard Treatment
Conditions: Anaplastic Oligoastrocytoma;   Anaplastic Astrocytoma;   Glioblastoma
Intervention: Drug: β-elemene
12 Recruiting A Phase III Trial on Adjuvant Temozolomide With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas
Conditions: Anaplastic Oligoastrocytoma;   Anaplastic Astrocytoma;   Glioblastoma
Interventions: Drug: Temozolomide;   Drug: α-IFN
13 Recruiting Impact of Surgery on the Treatment of Supratentorial Malignant Gliomas in Subjects Aged 70 and Over
Condition: Malignant Glioma
Interventions: Procedure: Surgery;   Radiation: radiotherapy

Study has passed its completion date and status has not been verified in more than two years.